According to Gram Research analysis, nearly all children with transfusion-dependent thalassemia (96 percent of 93 studied) have low vitamin D levels due to iron buildup from blood transfusions. Vitamin D supplements successfully raised levels to healthy ranges in 67 percent of children within 6 weeks, but 77 percent of those children’s levels dropped back down within 3 months after stopping treatment. This finding shows that children with thalassemia need ongoing vitamin D support rather than a single course of supplements.
Children with transfusion-dependent thalassemia, a serious blood disorder, almost always have low vitamin D levels because of iron buildup in their bodies. Researchers studied 93 children to see if vitamin D supplements could help. While supplements worked at first, most kids’ vitamin D levels dropped again after treatment stopped. The study shows these children need regular check-ups and ongoing vitamin D support, not just a one-time fix. This finding could help doctors create better treatment plans for kids with this condition.
Key Statistics
A 2026 prospective study of 93 children with transfusion-dependent thalassemia found that 96 percent had low vitamin D levels at baseline, with an average level of 11.63 ng/mL compared to the healthy range of 30 ng/mL or higher.
Vitamin D supplementation (60,000 IU weekly for 6 weeks) brought 67 percent of children with thalassemia to healthy vitamin D levels, but 77 percent of those children’s levels dropped back to deficient or insufficient ranges within 3 months after stopping treatment.
In a study of 93 children with transfusion-dependent thalassemia, baseline vitamin D levels showed a strong negative correlation with iron overload (ferritin levels), with a correlation coefficient of -0.664, indicating that iron buildup is a major driver of vitamin D deficiency.
A second round of vitamin D supplementation resulted in sufficiency in 69 percent of children with thalassemia whose levels had dropped after the first treatment course ended, suggesting that repeated or ongoing supplementation may be necessary.
The Quick Take
- What they studied: Whether vitamin D supplements could fix low vitamin D levels in children with transfusion-dependent thalassemia, a blood disorder that requires regular blood transfusions.
- Who participated: 93 children aged 1 to 18 years old who all had transfusion-dependent thalassemia. Almost all of them (96 percent) had low vitamin D when the study started.
- Key finding: Vitamin D supplements worked well at first, bringing 67 percent of children to healthy levels. However, three months after stopping the supplements, 77 percent of those children’s vitamin D levels dropped back down again.
- What it means for you: If your child has thalassemia and low vitamin D, supplements can help quickly, but they’ll likely need ongoing treatment rather than a single course. Regular blood tests are important to catch when levels drop again. Talk to your doctor about a long-term vitamin D plan instead of expecting one treatment to solve the problem permanently.
The Research Details
Researchers followed 93 children with transfusion-dependent thalassemia over several months. At the start, they measured each child’s vitamin D level using a blood test. Children with low or medium vitamin D received weekly vitamin D supplements (60,000 IU per week) plus calcium for 6 weeks. After 3 months, doctors tested their vitamin D levels again to see if the supplements worked. Children whose levels didn’t improve enough got another round of supplements, while those who improved were watched to see if their levels stayed healthy.
This type of study, called a prospective observational study, means researchers followed real patients over time and recorded what happened naturally, rather than randomly assigning some children to get supplements and others to get a fake treatment. This approach is useful for understanding how treatments work in actual medical practice.
The researchers also looked for patterns, such as whether iron buildup in the body (measured by ferritin levels) affected vitamin D status. This helped them understand why children with thalassemia struggle with vitamin D in the first place.
Understanding how vitamin D supplements work in children with thalassemia is important because these children face unique challenges. Their blood disorder and the iron that builds up from regular transfusions can interfere with how their bodies make and use vitamin D. By studying real children in actual treatment settings, researchers can figure out what doctors should actually do in their offices, not just what works in theory.
This study has several strengths: it included a large group of children (93), measured vitamin D levels with a standard blood test, and followed children over time to see what happened after treatment. However, the study didn’t compare these children to a control group that didn’t receive supplements, so we can’t be 100 percent certain the supplements caused the improvement. The study also didn’t explore all possible reasons why vitamin D levels dropped again after treatment stopped. The findings are most reliable for children with transfusion-dependent thalassemia and may not apply to other types of thalassemia or other conditions.
What the Results Show
Almost all children in the study (96 percent) had low vitamin D when tested at the beginning. Their average vitamin D level was very low at 11.63 ng/mL, compared to the healthy range of 30 ng/mL or higher. After receiving vitamin D supplements for 6 weeks, about two-thirds of the children (67 percent) reached healthy vitamin D levels. This showed that supplements can work quickly and effectively.
However, the most striking finding was what happened next. When doctors checked the children’s vitamin D levels again 3 months after stopping the supplements, most of the improvement had disappeared. About 77 percent of children whose levels had improved went back to having low vitamin D. This means that stopping supplements led to a rapid drop in vitamin D levels for most children. When doctors gave a second round of supplements to children whose levels had dropped again, about 69 percent improved once more.
The researchers also discovered an important connection: children with higher iron buildup in their bodies (measured by ferritin levels) tended to have lower vitamin D. This strong relationship suggests that iron overload from transfusions is a major reason why these children struggle with vitamin D.
The study found that only 23 percent of children who reached healthy vitamin D levels managed to keep them at the 3-month follow-up without additional treatment. This low maintenance rate is a key finding because it shows that one course of supplements is not enough for most children. The strong negative correlation between iron levels and vitamin D (a statistical measure of -0.664) indicates that iron buildup is a major factor driving vitamin D deficiency in this population. This suggests that managing iron levels might be just as important as giving vitamin D supplements.
Previous research has shown that low vitamin D is common in children with thalassemia, but this study provides new information about how well supplements work and how long the benefits last. Earlier studies suggested that iron overload interferes with vitamin D, and this research confirms that connection with strong statistical evidence. The finding that most children lose their vitamin D improvement after stopping supplements is important because it suggests that previous treatment approaches, which may have assumed one course of supplements would be enough, are not adequate. This study adds to growing evidence that children with thalassemia need ongoing vitamin D management, not just one-time treatment.
This study followed children over only 3 months, so we don’t know what happens to vitamin D levels over years. The study didn’t include a comparison group of children who didn’t receive supplements, so while we can see that levels improved, we can’t be completely certain the supplements caused the improvement rather than something else. The research didn’t explore why vitamin D levels dropped so quickly after supplements stopped, which would help doctors understand the best long-term strategy. The study was conducted in one location in India, so results might differ in other countries with different climates, diets, or healthcare practices. Finally, the study didn’t measure whether improving vitamin D levels actually improved children’s health outcomes, such as bone strength or overall quality of life.
The Bottom Line
Children with transfusion-dependent thalassemia should have their vitamin D levels checked regularly, at least every 3 months. If levels are low, vitamin D supplements (60,000 IU weekly for 6 weeks) combined with calcium appear effective based on this research. However, expect that vitamin D levels will likely drop again after stopping supplements, so plan for ongoing treatment rather than a one-time fix. Doctors should consider maintenance supplementation, meaning regular doses to keep levels healthy rather than waiting for levels to drop before treating again. These recommendations are based on solid evidence from a study of 93 children, though more research is needed to determine the best long-term dosing strategy.
This research is most relevant to children with transfusion-dependent thalassemia and their families, as well as doctors who treat this condition. Parents of children with thalassemia should discuss vitamin D screening and supplementation with their child’s doctor. Children with other types of thalassemia or other blood disorders may benefit from similar approaches, but this study specifically studied transfusion-dependent thalassemia. Adults with thalassemia might have different vitamin D needs and should consult their own doctors. People without thalassemia don’t need to change their vitamin D approach based on this research.
Vitamin D supplements appear to raise levels within 6 weeks based on this study. However, expect that levels will start dropping again within a few weeks to months after stopping supplements. If your child starts a maintenance supplementation plan, it may take several months of consistent treatment to establish stable vitamin D levels. The full benefit of maintaining healthy vitamin D levels, such as improved bone health, may take many months or years to become apparent.
Frequently Asked Questions
Why do children with thalassemia have low vitamin D levels?
Children with transfusion-dependent thalassemia develop low vitamin D because iron builds up in their bodies from regular blood transfusions. This iron overload interferes with how the body makes and uses vitamin D. Research shows a strong connection between iron levels and vitamin D deficiency in these children.
How long does vitamin D supplementation take to work in children with thalassemia?
Vitamin D supplements appear to work relatively quickly in children with thalassemia. A study of 93 children found that 67 percent reached healthy vitamin D levels within 6 weeks of taking 60,000 IU weekly supplements combined with calcium.
Do children with thalassemia need to take vitamin D supplements forever?
Based on current research, most children with transfusion-dependent thalassemia will need ongoing vitamin D support rather than a one-time treatment. A study found that 77 percent of children whose vitamin D improved lost that improvement within 3 months after stopping supplements, suggesting long-term maintenance treatment is necessary.
What should I do if my child with thalassemia has low vitamin D?
Talk to your child’s doctor about vitamin D screening and supplementation. If levels are low, supplements combined with calcium appear effective. Plan for regular blood tests every 3 months to monitor levels, and expect that your child may need ongoing supplements rather than just one course of treatment.
Can vitamin D supplements fix the iron overload problem in thalassemia?
Vitamin D supplements address the vitamin D deficiency but do not treat the underlying iron overload that causes it. Managing iron levels through other treatments remains important. Vitamin D supplementation is one part of comprehensive care for children with thalassemia, not a complete solution.
Want to Apply This Research?
- Set up a quarterly vitamin D level tracking reminder in your health app. Log the date of each blood test and the vitamin D level result (measured in ng/mL). Create a target range of 30 to 100 ng/mL and track whether results fall in, above, or below this range. This helps you and your doctor spot when levels are dropping and need intervention.
- If your child is prescribed vitamin D supplements, set up a weekly reminder in your app for the exact day and time to take the supplement. Create a simple checklist to mark off each weekly dose. If your doctor recommends ongoing maintenance supplements, set monthly reminders to refill prescriptions before they run out. This prevents gaps in treatment that could allow vitamin D levels to drop.
- Create a long-term tracking dashboard that shows vitamin D levels over time as a graph or chart. Include notes about when supplements were started, stopped, or changed. Track any symptoms your child reports, such as bone pain or fatigue, to see if they correlate with vitamin D levels. Share this data with your child’s doctor at each visit to help them make informed decisions about supplementation.
This article summarizes research findings and is not medical advice. Vitamin D supplementation decisions should be made with your child’s doctor, who can assess individual needs based on blood tests and medical history. The findings apply specifically to children with transfusion-dependent thalassemia and may not apply to other conditions. Do not start, stop, or change any supplements without consulting your healthcare provider. If your child experiences symptoms such as bone pain, weakness, or other health concerns, contact your doctor immediately.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.